Cargando…
The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis
BACKGROUND AND AIMS: Glucose phosphate isomerase (GPI) deficiency is an extremely rare autosomal recessive disorder caused by mutations in the GPI gene. In this research, the proband displaying typical manifestations of haemolytic anaemia and his family members were recruited to analyse the pathogen...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332073/ https://www.ncbi.nlm.nih.gov/pubmed/37430284 http://dx.doi.org/10.1186/s12920-023-01603-x |
_version_ | 1785070370178465792 |
---|---|
author | Wang, Yang Liu, Tao Liu, Jiaqi Xiang, Yan Huang, Lan Li, Jiacheng An, Xizhou Cui, Shengyan Feng, Zishuai Yu, Jie |
author_facet | Wang, Yang Liu, Tao Liu, Jiaqi Xiang, Yan Huang, Lan Li, Jiacheng An, Xizhou Cui, Shengyan Feng, Zishuai Yu, Jie |
author_sort | Wang, Yang |
collection | PubMed |
description | BACKGROUND AND AIMS: Glucose phosphate isomerase (GPI) deficiency is an extremely rare autosomal recessive disorder caused by mutations in the GPI gene. In this research, the proband displaying typical manifestations of haemolytic anaemia and his family members were recruited to analyse the pathogenicity of the detected variants. METHODS: Peripheral blood samples were collected from the family members and genomic DNA was extracted and targeted for capture and sequencing. The effect of the candidate pathogenic variants on splicing was further investigated using the minigene splicing system. The computer simulation was also used for further analysis of the detected data. RESULTS: The proband carried the compound heterozygous variants c.633 + 3 A > G and c.295G > T in the GPI gene, which have never been reported before. In the genealogy, co-segregation of the mutant genotype with the phenotype was established. The minigene study showed that intronic mutations resulted in abnormal pre-mRNA splicing. Specifically, the two aberrant transcripts: r.546_633del and r.633 + 1_633 + 2insGT were transcribed by the minigene plasmid expressing the c.633 + 3 A > G variant. The missense mutation c.295G > T in exon 3 resulted in altering glycine at codon 87 to cysteine which was predicted to be pathogenic in an in silico analysis. Deeper analyses revealed that the Gly87Cys missense mutation led to steric hindrance. Compared to the wild-type, the mutation G87C led to a significant increase in intermolecular forces. CONCLUSION: Overall, the novel compound heterozygous variants in the GPI gene contributed to the etiology of the disease. Genetic testing can assist in the diagnosis. The novel gene variants identified in the present study has further expanded the mutational spectrum of GPI deficiency, which can better guide family counselling. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12920-023-01603-x. |
format | Online Article Text |
id | pubmed-10332073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-103320732023-07-11 The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis Wang, Yang Liu, Tao Liu, Jiaqi Xiang, Yan Huang, Lan Li, Jiacheng An, Xizhou Cui, Shengyan Feng, Zishuai Yu, Jie BMC Med Genomics Research BACKGROUND AND AIMS: Glucose phosphate isomerase (GPI) deficiency is an extremely rare autosomal recessive disorder caused by mutations in the GPI gene. In this research, the proband displaying typical manifestations of haemolytic anaemia and his family members were recruited to analyse the pathogenicity of the detected variants. METHODS: Peripheral blood samples were collected from the family members and genomic DNA was extracted and targeted for capture and sequencing. The effect of the candidate pathogenic variants on splicing was further investigated using the minigene splicing system. The computer simulation was also used for further analysis of the detected data. RESULTS: The proband carried the compound heterozygous variants c.633 + 3 A > G and c.295G > T in the GPI gene, which have never been reported before. In the genealogy, co-segregation of the mutant genotype with the phenotype was established. The minigene study showed that intronic mutations resulted in abnormal pre-mRNA splicing. Specifically, the two aberrant transcripts: r.546_633del and r.633 + 1_633 + 2insGT were transcribed by the minigene plasmid expressing the c.633 + 3 A > G variant. The missense mutation c.295G > T in exon 3 resulted in altering glycine at codon 87 to cysteine which was predicted to be pathogenic in an in silico analysis. Deeper analyses revealed that the Gly87Cys missense mutation led to steric hindrance. Compared to the wild-type, the mutation G87C led to a significant increase in intermolecular forces. CONCLUSION: Overall, the novel compound heterozygous variants in the GPI gene contributed to the etiology of the disease. Genetic testing can assist in the diagnosis. The novel gene variants identified in the present study has further expanded the mutational spectrum of GPI deficiency, which can better guide family counselling. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12920-023-01603-x. BioMed Central 2023-07-10 /pmc/articles/PMC10332073/ /pubmed/37430284 http://dx.doi.org/10.1186/s12920-023-01603-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wang, Yang Liu, Tao Liu, Jiaqi Xiang, Yan Huang, Lan Li, Jiacheng An, Xizhou Cui, Shengyan Feng, Zishuai Yu, Jie The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis |
title | The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis |
title_full | The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis |
title_fullStr | The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis |
title_full_unstemmed | The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis |
title_short | The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis |
title_sort | novel compound heterozygous variants identified in a chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332073/ https://www.ncbi.nlm.nih.gov/pubmed/37430284 http://dx.doi.org/10.1186/s12920-023-01603-x |
work_keys_str_mv | AT wangyang thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT liutao thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT liujiaqi thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT xiangyan thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT huanglan thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT lijiacheng thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT anxizhou thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT cuishengyan thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT fengzishuai thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT yujie thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT wangyang novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT liutao novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT liujiaqi novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT xiangyan novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT huanglan novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT lijiacheng novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT anxizhou novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT cuishengyan novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT fengzishuai novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis AT yujie novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis |